Analysis of caspofungin combined with clindamycin for severe pneumocystis pneumonia
10.13699/j.cnki.1001-6821.2016.04.021
- VernacularTitle:卡泊芬净联合克林霉素治疗重症肺孢子菌肺炎的案例分析
- Author:
Qing-Tao ZHOU
1
;
Ning SHEN
;
Meng WANG
;
Li-Na SUN
;
Yan-Ling DING
;
Bei HE
Author Information
1. 北京大学第三医院呼吸内科
- Keywords:
pneumocystis;
pneumonia;
caspofungin;
clindamycin
- From:
The Chinese Journal of Clinical Pharmacology
2016;(4):351-353
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic value of caspofun-gin combined with clindamycin for pneumocystis pneumonia ( PCP ).Methods The clinical data of two severe PCP patients treated by caspo-fungin combined with clindamycin regimen in department of respiratory medicine of our hospital were analyzed.Because of definitely sulfame-thoxazole/trimethoprim (SMZ/TMP) allergy history, they were both ini-tially treated with caspofungin single drug , and received mechanical ven-tilation and methylprednisolone treatment.However , clindamycin was added to both patients after 3-4 days because of poor response to caspo-fungin monotherapy.Then they got better gradually , the arterial blood gas and chest CT scan showed that the respiratory failure and lung infil-tration were much improved.Results and Conclusion The courses of caspofungin combined with clindamycin were both 3 weeks, the patients were cured without adverse drug reactions.For PCP patients with limited usage of SMZ/TMP, caspofungin combined with clindamycin may be an effective and safe regimen.